Cadrenal Therapeutics, Inc.
New Filing
CIK: 0001937993·Biotechnology·DELAWARE·Filed: Apr 6, 2026
Total Offering
$7,923,235
Amount Sold
$7,923,235
Investors
1
First Sale
Apr 1, 2026
Offering Details
- Type
- Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2022
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Quang X. Pham | |
| Matthew Szot | |
| James Ferguson | |
| Jeffrey Cole | |
| John R. Murphy | |
| Steven Zelenkofske | |
| Glynn Wilson | |
| Lee Golden |
Company
SEC Filing
0001213900-26-040457
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free